Financials in USD. Standardized financial statements.
A compact view of how BioNexus Gene Lab Corp. turns revenue into operating income and net income.
| Metric | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue? | $7.42M | $9.51M | $9.77M | $10.93M | $13.36M | $11.39M | $126,955 | $212,328 | $107,680 | $0 |
| Revenue Growth? | -21.9% | -2.7% | -10.6% | -18.2% | +17.3% | +8872.0% | -40.2% | +97.2% | 0.0% | 0.0% |
| Cost of Revenue? | $6.34M | $8.22M | $8.44M | $9.67M | $11.17M | $9.67M | $71,067 | $183,563 | $28,871 | $0 |
| Gross Profit? | $1.09M | $1.29M | $1.33M | $1.26M | $2.19M | $1.72M | $55,888 | $28,765 | $78,809 | $0 |
| Gross Margin? | +14.6% | +13.6% | +13.6% | +11.5% | +16.4% | +15.1% | +44.0% | +13.5% | +73.2% | 0.0% |
| Operating Expenses? | $4.24M | $2.86M | $3.92M | $1.55M | $1.14M | $446,000 | $331,593 | -$31,136 | $206,715 | $835 |
| Operating Income? | -$3.16M | -$1.57M | -$2.59M | -$291,177 | $1.06M | $1.27M | -$275,705 | $59,901 | -$127,910 | -$840 |
| EBITDA? | -$2.80M | -$1.42M | -$2.49M | -$185,761 | $1.16M | $1.38M | -$222,373 | $100,512 | -$104,383 | $0 |
| Income Before Tax | -$2.98M | -$1.59M | -$2.61M | -$303,656 | $1.04M | $1.26M | -$275,705 | $59,901 | -$119,414 | -$835 |
| Income Tax Expense | $0 | $3,494 | $21,526 | $52,310 | $291,283 | $168,411 | -$29,236 | $33,447 | $4,336 | $0 |
| Net Income? | -$2.98M | -$1.60M | -$2.63M | -$355,966 | $751,571 | $1.09M | -$246,469 | $26,454 | -$123,750 | -$835 |
| EPS? | $-1.61 | $-0.90 | $-1.53 | $-0.25 | $0.53 | $1.28 | $-0.03 | $0.00 | $-0.02 | $-0.00 |
| Diluted EPS? | $-1.61 | $-0.90 | $-1.53 | $-0.25 | $0.53 | $1.28 | $-0.03 | $0.00 | $-0.02 | $-0.00 |
Revenue, profitability, margins, EPS, and share-count trends over time.
Top-line demand and scale over time
Profit left after direct production costs
Core business profitability before financing and tax
Bottom-line profit after all expenses
Profit allocated to each diluted share
Share count trend that affects EPS quality
Gross, operating, and net margin quality